Similar articles

• The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments.

  Klonoff DC, Fleming A, Gabbay R. Klonoff DC, et al. J Diabetes Sci Technol. 2020 Nov;14(6):987-989. doi: 10.1177/1932296819891036. Epub 2019 Nov 19. J Diabetes Sci Technol. 2020. PMID: 31744326 Free PMC article. No abstract available.
• [Hypoglycemia--simply annoying or dangerous?].

  Kern W. Kern W. MMW Fortschr Med. 2016 Jun 9;158(11):67-70. doi: 10.1007/s15006-016-8385-8. MMW Fortschr Med. 2016. PMID: 27271419 Review. German. No abstract available.
• Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).

  Edelman SV, Callahan P, Deeb LC. Edelman SV, et al. Diabetes Technol Ther. 2000 Summer;2(2):233-8. doi: 10.1089/15209150050025195. Diabetes Technol Ther. 2000. PMID: 11469264
• Analysis: high-tech diabetes technology and the myth of clinical "plug and play".

  Weinzimer SA. Weinzimer SA. J Diabetes Sci Technol. 2010 Nov 1;4(6):1465-7. doi: 10.1177/193229681000400621. J Diabetes Sci Technol. 2010. PMID: 21129342 Free PMC article.
• Which threshold to detect hypoglycemia? Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity.

  Reach G. Reach G. Diabetes Care. 2001 May;24(5):803-4. doi: 10.2337/diacare.24.5.803. Diabetes Care. 2001. PMID: 11347733 Review. No abstract available.